SS
APTO

SBI Securities’s Aptose Biosciences, Inc. APTO Stock Holding History

SBI Securities’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$13 – 4282
2025
Q1 		$13 Sell
4
-1
-20% -$5 ﹤0.01% 3934
2024
Q4 		$30 Buy
+5
New +$46 ﹤0.01% 3752

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

SBI Securities's APTO Position: Q2 2025 in Review

SBI Securities sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 4 shares — an estimated $13 sold.

SBI Securities first reported a position in APTO in Q4 2024 and held it in 2 quarters. The position peaked at $30 in Q4 2024. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • SBI Securities reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • SBI Securities sold 4 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $13.
  • SBI Securities first reported a position in Aptose Biosciences, Inc. in Q4 2024 and held it in 2 quarters.
  • SBI Securities's Aptose Biosciences, Inc. position peaked at $30 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.